Harbin Jixianglong Biotech Co., Ltd.
Drug Recalls (Class II)
Class II
D-0379-2026
·
20260311
·
Ongoing
Product
Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04 Manufacturer: Ha...
Reason for Recall
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Distribution
Nationwide within the United States
Source: openFDA Enforcement API